EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rise in Serum 25-Hydroxyvitamin D Levels during the COVID-19 Pandemic

Witt Durden, Shady Ezaldin, Jessica Amos, Suzanne Kemper iD, James Campbell

Nutrients · 2024

DOI: 10.3390/nu16152449 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Witt Durden und 4 weiteren Autor:innen. Beteiligte Einrichtung: Charleston Area Medical Center, Institute for Academic Medicine, 3200 MacCorkle Ave SE, Charleston, WV 25304, USA. Hauptthemen laut MEDLINE: COVID-19, Vitamin D, Dietary Supplements, SARS-CoV-2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

With the emergence of the COVID-19 pandemic, the absence of established evidence-based treatment protocols led healthcare professionals and the public to explore experimental treatments, including high doses of vitamin D supplements. This study aimed to assess changes in serum 25-hydroxyvitamin D levels during the pandemic, employing a retrospective cohort analysis of data from Charleston Area Medical Center (CAMC). The study analyzed serum 25-hydroxyvitamin D levels in a cohort of 35,556 patients treated at CAMC in 2019, a representative pre-pandemic period, to 2021, a representative pandemic period. Our findings revealed a significant increase in mean serum 25-hydroxyvitamin D levels as compared with 2019 (37 ± 21 vs. 31 ± 15 ng/mL, p ≤ 0.001). Additionally, in 2021, there were significantly more patients exhibiting serum levels in the highest quintiles, specifically >100 ng/mL (1.6% vs. 0.2%), 75–100 ng/mL (4.6% vs. 1.2%), and 50–75 ng/mL (16.0% vs. 8.4%), p ≤ 0.001. This upsurge suggests increased intake of vitamin D supplements, potentially fueled by widespread discussions that were taking place largely on the internet regarding the efficacy of vitamin D against COVID-19. Our findings underscore the critical need for evidence-based public health messaging, especially during health crises, to prevent unnecessary health risks and ensure patient safety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Vitamin DDietary SupplementsSARS-CoV-2Vitamin D DeficiencyHumansFemaleMaleRetrospective StudiesMiddle AgedAdultPandemicsAged

Stichwörter der Autor:innen

COVID-19hypervitaminosis Dserum 25-hydroxyvitamin Dvitamin D

Substanzen

Vitamin D25-hydroxyvitamin D

Autor:innen und Institutionen

  • Charleston Area Medical Center, Institute for Academic Medicine, 3200 MacCorkle Ave SE, Charleston, WV 25304, USA.
  • Department of Internal Medicine, West Virginia University-Charleston Division, Charleston, WV 25304, USA.

ORCID-Profile: Suzanne Kemper

Zitieren

APA

Durden, W., Ezaldin, S., Amos, J., Kemper, S., & Campbell, J. (2024). Rise in Serum 25-Hydroxyvitamin D Levels during the COVID-19 Pandemic. Nutrients. https://doi.org/10.3390/nu16152449

Vancouver

Durden W, Ezaldin S, Amos J, Kemper S, Campbell J. Rise in Serum 25-Hydroxyvitamin D Levels during the COVID-19 Pandemic. Nutrients. 2024. doi:10.3390/nu16152449

BibTeX
@article{Durden2024,
  author = {Durden, Witt and Ezaldin, Shady and Amos, Jessica and Kemper, Suzanne and Campbell, James},
  title = {Rise in Serum 25-Hydroxyvitamin D Levels during the COVID-19 Pandemic},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16152449}
}
Kostenlos starten →